Gradient Investments LLC Moderna, Inc. Transaction History

Gradient Investments LLC

$3.55 Billion
Q1 2024

A detailed history of Gradient Investments LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Gradient Investments LLC holds 32 shares of MRNA stock, worth $3,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 78 58.97%

Holding current value

$3,710

Previous $7,000 57.14%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$85.37 - $115.44 $3,927 - $5,310	-46 Reduced 58.97%	32 $3,000
Q4 2023 Jan 18, 2024	BUY	$69.51 - $104.43 $1,112 - $1,670	16 Added 25.81%	78 $7,000
Q3 2023 Oct 27, 2023	SELL	$96.41 - $126.61 $19,764 - $25,955	-205 Reduced 76.78%	62 $6,000
Q2 2023 Jul 11, 2023	SELL	$118.5 - $160.53 $1,540 - $2,086	-13 Reduced 4.64%	267 $32,000
Q1 2023 Apr 17, 2023	SELL	$135.66 - $197.02 $678 - $985	-5 Reduced 1.75%	280 $43,000

Q4 2022 Jan 10, 2023	BUY	$118.38 - $210.04 $26,635 - $47,259	225 Added 375.0%	285 $0
Q2 2022 Jul 11, 2022	BUY	$117.13 - $176.59 $2,928 - $4,414	25 Added 71.43%	60 $9,000
Q1 2022 May 26, 2022	SELL	$126.46 - $235.05 $8,852 - $16,453	-70 Reduced 66.67%	35 $6,000
Q4 2021 Jan 12, 2022	BUY	$225.82 - $368.51 $22,582 - $36,851	100 Added 2000.0%	105 $27,000
Q3 2021 Oct 18, 2021	BUY	$221.9 - $484.47 $1,109 - $2,422	5 New	5 $2,000
Q1 2021 Apr 21, 2021	SELL	$109.18 - $185.98 $10,918 - $18,598	-100 Closed	0 $0
Q3 2020 Oct 06, 2020	BUY	$54.34 - $94.85 $3,151 - $5,501	58 Added 138.1%	100 $7,000
Q2 2020 Jul 10, 2020	BUY	$29.67 - $80.0 $1,246 - $3,360	42 New	42 $3,000

Others Institutions Holding MRNA

# of Institutions

1,038

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Moderna, Inc. Transaction History